logo

Dbv Technologies S.A. - (DBVT)



Trade DBVT now with
  Date
  Headline
6/26/2019 1:32:46 AM DBV Technologies Appoints Pharis Mohideen As Chief Medical Officer
12/20/2018 6:16:27 AM Jefferies Lowers DBV Technologies S.A. - (DBVT) To Hold From Buy With $8 Down From $37 Price Target
12/12/2018 1:33:28 AM DBV Tech Highlights Data Supporting Induction Of Immunotolerance Through Skin At Inflammatory Skin Disease Summit
10/26/2018 1:35:15 AM DBV Technologies Begins Part B Of Phase III Study In Peanut-Allergic Toddlers
10/22/2018 1:33:10 AM DBV Technologies Announces Submission Of BLA For Viaskin Peanut To FDA
9/12/2018 1:32:22 AM DBV Technologies Report Positive DSMB Review Of Part A Of Phase III Study In Peanut-Allergic Toddlers
5/29/2018 1:33:34 AM DBV Technologies Shows Commitment To The Development Of Treatments For Food Allergies At EAACI 2018
3/21/2018 3:32:28 AM DBV Technologies Reports Pricing Of $150.0 Mln Global Offering Of Ordinary Shares
3/15/2017 5:47:29 PM Jefferies Is Lowering DBV Technologies S.A. - (DBVT) 2018 Estimate To -6.36 From -5.56
3/15/2017 5:47:13 PM Jefferies Is Cutting DBV Technologies S.A. - (DBVT) 2017 Estimate To -6.94 From -5.67
4/7/2016 12:36:13 PM Jefferies Is Increasing DBV Technologies S.A. - (DBVT) 2017 Rev. Estimate To 6.0 M From 5.3 M
4/7/2016 12:36:01 PM Jefferies Is Raising DBV Technologies S.A. - (DBVT) 2016 Rev. Estimate To 6.0 M From 5.3 M
4/7/2016 12:34:49 PM Jefferies Is Cutting DBV Technologies S.A. - (DBVT) FY 18 Estimate To -4.22 From -3.95
4/7/2016 12:34:35 PM Jefferies Is Lowering DBV Technologies S.A. - (DBVT) FY 17 Estimate To -4.09 From -3.70